Emmes: Advantage eClinical
Contract research organization (CRO) Emmes has introduced its third-generation version of Advantage eClinical. The cloud platform (available as a standalone software product) is designed to accelerate study builds, increase flexibility, and provide insights to sponsors.einsights to clinical trial sponsors of all sizes.
“One of the challenges many smaller biotechs face in the market is they don’t have access to an integrated technology platform for their trials; options are incredibly limited and expensive, and they are often inflexible and lack support,” commented Hemang Maniar, Emmes chief information officer. “This is exactly what we have set out to address with our third-generation Advantage eClinical platform.”
